JANA Vol 9 #1 - American Nutraceutical Association

effect of dietary treatment on lipid peroxidation and antioxidant
status in newly diagnosed noninsulin dependent diabetes.
Free Radic Biol Med. 1996;21(5):719-26.
12. Hunt JV, Smith CC, Wolff SP. Autoxidative glycosylation and
possible involvement of peroxides and free radicals in LDL
modification by glucose. Diabetes. 1990;39(11):1420-4.
13. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of
oxidative stress study II: are oxidation products of lipids, proteins,
and DNA markers of CCl4 poisoning? Free Radic Biol
Med. 2005;38(6):698-710.
14. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of
oxidative stress study III. Effects of the nonsteroidal antiinflammatory
agents indomethacin and meclofenamic acid on
measurements of oxidative products of lipids in CCl4 poisoning.
Free Radic Biol Med. 2005;38(6):711-8.
15. Dincer Y, Akcay T, Alademir Z, Ilkova H. Assessment of DNA
base oxidation and glutathione level in patients with type 2
diabetes. Mutat Res. 2002;505(1-2):75-81.
16. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol
diglucoside (SDG) isolated from flax-seed. Mol Cell
Biochem. 1997;168:117-123.
17. Prasad K. Oxidative stress as a mechanism of diabetes in diabetic
BB prone rats: effect of secoisolariciresinol diglucoside
(SDG). Mol Cell Biochem. 2000;209(1-2):89-96.
18. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived
metabolites, secoisolariciresinol, enterodiol, and
enterolactone. Int J Angiology. 2000;9(4):220-225.
19. Prasad K. Secoisolariciresinol diglucoside from flaxseed
delays the development of type 2 diabetes in Zucker rat. J Lab
Clin Med. 2001;138(1):32-9.
20. Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU.
Antioxidant activity of the flaxseed lignan secoisolariciresinol
diglucoside and its mammalian lignan metabolites enterodiol
and enterolactone. Mol Cell Biochem. 1999;202(1-2):91-100.
21. Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of
hypercholesterolemic atherosclerosis by CDC-flaxseed with very
low alpha-linolenic acid. Atherosclerosis. 1998;136(2):367-75.
22. Jenkins DJ, Kendall CW, Vidgen E, et al. Health aspects of
partially defatted flaxseed, including effects on serum lipids,
oxidative measures, and ex vivo androgen and progestin activity:
a controlled crossover trial. Am J Clin Nutr.
1999;69(3):395-402.
23. Prasad K. Reduction of serum cholesterol and hypercholesterolemic
atherosclerosis in rabbits by secoisolariciresinol diglucoside
isolated from flaxseed. Circulation. 1999;99(10):1355-62.
24. Prasad K. Hypocholesterolemic and antiatherosclerotic effect
of flax lignan complex isolated from flaxseed. Atherosclerosis.
2005;179(2):269-75.
25. Wiesenborn D, Tostenson K, Kangas N. Continuous abrasive
method for mechanically fractionating flaxseed. J Am Oil
Chem Soc. 2003;80:295-300.
26. Garrow JS, Webster J. Quetelet's index (W/H2 ) as a measure
of fatness. Int J Obes. 1985;9(2):147-53.
27. Mares-Perlman JA, Klein BE, Klein R, Ritter LL, Fisher MR,
Freudenheim JL. A diet history questionnaire ranks nutrient
intakes in middle-aged and older men and women similarly to
multiple food records. J Nutr. 1993;123(3):489-501.
28. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type
2 diabetes mellitus by changes in lifestyle among subjects with
impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-
50.
29. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction
in the incidence of type 2 diabetes with lifestyle intervention
or metformin. N Engl J Med. 2002;346(6):393-403.
30. Prasad K, Mantha SV, Muir AD, Westcott ND. Protective
effect of secoisolariciresinol diglucoside against streptozotocin-induced
diabetes and its mechanism. Mol Cell Biochem.
2000;206(1-2):141-9.
31. Prasad K. Flaxseed: a source of hypocholesterolemic and
antiatherogenic agents. Drug News Perspect. 2000;13(2):99-
104.
32. Hayward AR, Shriber M, Sokol R. Vitamin E supplementation
reduces the incidence of diabetes but not insulitis in NOD
mice. J Lab Clin Med. 1992;119(5):503-7.
33. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H,
Tarui S. Preventive and therapeutic effects of large-dose
nicotinamide injections on diabetes associated with insulitis.
An observation in nonobese diabetic (NOD) mice. Diabetes.
1982;31(9):749-53.
34. Prasad K. Dietary flaxseed in prevention of hypercholesterolemic
atherosclerosis. Atherosclerosis. 1997;132(1):69-76.
35. Lucas EA, Lightfoot SA, Hammond LJ, et al. Flaxseed
reduces plasma cholesterol and atherosclerotic lesion formation
in ovariectomized Golden Syrian hamsters.
Atherosclerosis. 2004;173(2):223-9.
36. Bhathena SJ, Ali AA, Mohamed AI, Hansen CT, Velasquez
MT. Differential effects of dietary flaxseed protein and soy
protein on plasma triglyceride and uric acid levels in animal
models. J Nutr Biochem. 2002;13(11):684-689.
37. Bhathena SJ, Ali AA, Haudenschild C, et al. Dietary flaxseed
meal is more protective than soy protein concentrate against
hypertriglyceridemia and steatosis of the liver in an animal
model of obesity. J Am Coll Nutr. 2003;22(2):157-64.
38. Arjmandi BH, Khan D, Juma S, et al. Whole flaxseed consumption
lowers serum LDL-cholesterol and lipoprotein(a)
concentrations in postmenopausal women. Nutr Res.
1998;18(7):1203-1214.
39. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves
lipid profile without altering biomarkers of bone metabolism
in postmenopausal women. J Clin Endocrinol Metab.
2002;87(4):1527-32.
40. Slavin JL. Whole grains and human health. Nutr Res Rev.
2004;17:5:99-110.
41. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU,
Wolever TM, Jenkins DJ. Nutritional attributes of traditional
flaxseed in healthy young adults. Am J Clin Nutr.
1995;61(1):62-8.
42. Wendland E, Farmer AJ, Paul G, Neil A. Effect of alphalinolenic
acid on cardiovascular risk markers: a systematic
review. Heart. 2006;92:166-69.
34 JANA Vol. 9, No. 1, 2006